Optex Systems Holdings Inc. — Form 10-Q Summary
Business context and reporting period
Unaudited results cover the three and six months ended March 29, 2020, compared with March 31, 2019. Optex manufactures optical sighting systems, periscopes, rifle and surveillance sights, night-vision assemblies, and related optical products for the U.S. Department of Defense, defense contractors, foreign military customers, and commercial markets. Operations are conducted through the Richardson, Texas, and Applied Optics Center in Dallas segments, with 109 full-time equivalent employees.
Revenue concentration remained significant: approximately 54% from the U.S. government, 29% from three major U.S. defense contractors, 10% from one commercial customer, and 7% from other customers. Approximately 96% of revenue was domestic.
Financial performance and liquidity
| Metric | Three months ended March 29, 2020 | Three months ended March 31, 2019 | Six months ended March 29, 2020 | Six months ended March 31, 2019 |
|---|---|---|---|---|
| Revenue | $6.947 million | $7.088 million | $12.833 million | $12.979 million |
| Gross margin | $1.619 million; 23.3% | $1.981 million; 27.9% | $3.086 million; 24.0% | $3.423 million; 26.4% |
| Operating income | $781 thousand; 11.2% | $1.182 million; 16.7% | $1.499 million; 11.7% | $1.881 million; 14.5% |
| Net income | $1.944 million | $(973) thousand | $1.265 million | $1.052 million |
| Net income applicable to common shareholders | $1.311 million | $(973) thousand | $852 thousand | $704 thousand |
| Basic EPS | $0.15 | $(0.12) | $0.10 | $0.08 |
| Adjusted EBITDA | $871 thousand | $1.296 million | $1.681 million | $2.123 million |
Cash and cash equivalents were $1.670 million at March 29, 2020, compared with $1.068 million at September 29, 2019. Six-month operating cash flow was $752 thousand, capital expenditures were $96 thousand, financing cash use was $54 thousand, and net cash increased by $602 thousand.
Current assets were $15.563 million and current liabilities were $3.018 million, producing approximately $12.5 million of working capital. Accounts receivable were $3.926 million and inventory was $9.810 million. The company had $250 thousand outstanding under its Avidbank credit facility at March 29, 2020.
Total liabilities were $6.101 million and stockholders’ equity was $13.476 million. Adoption of ASC 842 resulted in recognition of a $1.615 million right-of-use asset and approximately $1.679 million of operating lease liabilities.
Material changes versus the prior comparable periods
- Quarterly revenue decreased 2.0%; six-month revenue decreased 1.1%. Richardson revenue declined $227 thousand in the quarter and $411 thousand year to date, partly offset by Applied Optics Center increases of $85 thousand and $265 thousand.
- Gross margin declined 460 basis points in the quarter and 240 basis points year to date, primarily because of product-mix changes and lower-margin periscope, optical assembly, and other product activity.
- Operating income declined $401 thousand in the quarter and $382 thousand year to date. General and administrative expense increased 4.9% in the quarter and 2.9% year to date, primarily from board changes, proxy costs, and the February 2020 shareholder meeting.
- Net income benefited from a noncash $1.332 million gain on warrant fair value in the quarter and an $81 thousand gain year to date, compared with a $1.932 million loss and $547 thousand loss, respectively, in the prior-year periods. The quarter also included $633 thousand of deemed dividends allocated to participating warrants.
- Adjusted EBITDA declined $425 thousand in the quarter and $442 thousand year to date, reflecting lower gross margins, product-mix changes, and higher operating expenses.
- Backlog was $21.9 million at March 29, 2020, down 11.0% from $24.6 million at September 29, 2019. Six-month order bookings were $10.1 million versus $15.2 million in the prior-year period.
Guidance, outlook, risks, and unusual items
- Management expects second-half fiscal 2020 revenue to approximate the first six months, with improved margins from product mix. It anticipates higher Richardson revenue from periscope and sighting-system deliveries and increased Applied Optics Center margins and order activity.
- Management expects positive net income, higher gross margins and adjusted EBITDA, and positive operating cash flow during 2020, but cautions that uneven customer deliveries, first-article inspections, COVID-19 disruptions, inventory needs, and production costs could create a working-capital shortfall.
- The company was classified as essential critical infrastructure and remained operational during COVID-19 restrictions. Through the filing date, disruption was minimal, although the company reported short-term supply delays, customer schedule revisions, and travel and trade-show disruptions.
- Management identified longer-duration pandemic effects, illness, supply-chain interruptions, customer demand, and potential pressure on congressional defense budgets as risks. No material change in previously disclosed risk factors was reported.
- On April 16, 2020, the company replaced the Avidbank facility with a $2.25 million BBVA USA facility maturing April 15, 2022. The facility bears interest at BBVA’s prime rate, fixed at 3% for the first year, is secured by substantially all assets, and includes a 1.25:1 fixed-charge coverage covenant and other customary covenants.
- The warrant liability was $1.955 million at March 29, 2020, based on 4.125 million outstanding warrants and Level 3 valuation inputs. The company repurchased all 25,000 outstanding stock options during the six months and had no stock options remaining at quarter-end.
- On April 30, 2020, the board approved increased annual compensation for the three independent directors and grants of 100,000 restricted shares to each director, vesting over five years.
- No material litigation was pending or threatened, and management concluded disclosure controls were effective as of March 29, 2020.
Investor verification points
- Verify whether projected second-half revenue and margin improvement were achieved, particularly in the Richardson periscope and Applied Optics Center product lines.
- Monitor backlog conversion, new task-order releases under IDIQ contracts, and the effect of the $35 million shared ICWS award, which is not fully included in backlog absent released task orders.
- Assess customer and supplier concentration, especially U.S. government and major defense-contractor exposure.
- Review COVID-19 effects on delivery schedules, supply availability, workforce continuity, and future defense spending.
- Track liquidity, covenant compliance, and borrowing availability under the BBVA facility.
- Separate recurring operating performance from noncash warrant fair-value gains or losses when evaluating earnings.